Federal agency, which normally supports state and local public health labs, has been hobbled by staff departuresSign up for the Breaking News US email to get newsletter alerts in your inboxThe US federal agency responsible for monitoring diseases has temporarily halted certain diagnostic testing, including those for rabies, human herpesvirus and several other infectious illnesses.The Centers for Disease Control and Prevention (CDC) released a list on Monday showing that more than two dozen types of testing are now unavailable. Continue reading...
β’ The biopic Michael delves into Michael Jackson's life, showcasing his fame highs and personal struggles, set for April 2026 release.
β’ Directed to offer an intimate look at the music icon beyond his public image, appealing to fans of music biopics.
β’ Listed among top films like Super Mario and The Drama, it elevates April 2026 as a significant month for Hollywood blockbusters.
β’ Defense Secretary Pete Hegseth announced 5,000 additional US troops to Poland on April 2, responding to Russian incursions 20 km into Ukraine near Lviv.
β’ Deployment includes Abrams tanks and HIMARS systems, totaling 15,000 US forces in Eastern Europe.
β’ Move signals NATO resolve as Ukraine reports 300 civilian deaths last week from shelling.
Leading US heart health group recommends prioritizing plant-based protein over meat relative to US governmentThe American Heart Associationβs new nutrition guidance, released on Tuesday, emphasized a dietary pattern rich in vegetables, βfruits and whole grains, prioritizing plant-based protein over meat.It also suggested limiting the βuse of sugar, salt and ultra-processed foods and replacing full fat dairy with non-fat and low-fat dairy. Continue reading...
β’ The Office of the United States Trade Representative submitted the 2026 National Trade Estimate Report to President Trump and Congress on March 31, 2026, detailing significant foreign trade barriers impacting U.S. exports.
β’ The annual report, due by March 31 each year, outlines Trump Administration strategies to address non-reciprocal practices and ensure a level playing field for American workers.
β’ It highlights barriers in key markets and proposes actions to counter discriminatory policies abroad, reinforcing U.S. trade priorities amid ongoing global tensions.
β’ The White House issued 'A National Policy Framework for Artificial Intelligence,' outlining legislative recommendations to advance U.S. AI priorities.
β’ This follows the July 2025 'Americaβs AI Action Plan' with over 90 policy actions across innovation, infrastructure, and international security, seeking business input on slowing regulations.
β’ The framework may limit funding to states with AI-restrictive rules, positioning the U.S. as the global AI leader.
β’ Berkshire Hathaway disclosed in SEC filings that its position in Apple has grown to $170 billion in market value, reinforcing Apple as the conglomerate's largest single equity holding at approximately 48% of total equity portfolio.
β’ The increase reflects both organic price appreciation of Apple shares and incremental purchases by Warren Buffett's investment team amid the company's strong iPhone 16 sales and services segment growth.
β’ The substantial concentration signals Berkshire's high conviction in Apple's long-term competitive moat, capital allocation discipline, and valuation at current levels, providing a powerful endorsement to institutional investors amid market volatility.
β’ The White House issued its National Policy Framework for Artificial Intelligence on March 20, 2026, guiding U.S. AI development.
β’ CSIS experts Navin Girishankar and Aalok Mehta discussed the framework's implications in a rapid round-up.
β’ The policy shapes U.S. AI leadership, influencing industry investments and regulations.
β’ The SPIRIT-HF study, presented at ACC.26 in New Orleans (March 28-30, 2026), found that spironolactone increased hospitalizations and serious adverse events in patients with HFpEF (heart failure with preserved ejection fraction) or HFmrEF (mildly reduced ejection fraction).
β’ Results raise significant safety questions about the drug's efficacy in these patient populations, potentially challenging current treatment protocols.
β’ The findings were presented to cardiologists and cardiovascular specialists at the American College of Cardiology's annual conference, the largest gathering of heart disease specialists.